Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for Cognitive Impairment in Cancer Survivors (urochester Trial)
N/A
Waitlist Available
Research Sponsored by Allison Magnuson
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be age 65 or older
Be independent in Activities of Daily Living (ADL)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
urochester Trial Summary
This trial is evaluating a cognitive behavioral therapy-based intervention (MAAT-G) specifically for older adults with cancer-related cognitive dysfunction (CRCD).
Who is the study for?
This trial is for older cancer survivors aged 65 or above with mild cognitive impairment (MCI). Participants must have completed chemotherapy, be able to consent, read English, and manage daily activities independently. Those unable to provide informed consent without a proxy or who don't meet the cognitive assessment criteria cannot join.Check my eligibility
What is being tested?
The study tests Memory and Attention Adaptation Training-Geriatrics (MAAT-G), a therapy designed for older adults to see if it can help with cognitive issues caused by chemotherapy. It's about whether this approach is practical and beneficial in improving mental functions like memory and attention.See study design
What are the potential side effects?
Since MAAT-G is a form of cognitive behavioral therapy rather than a drug, traditional side effects are not expected. However, participants may experience fatigue or emotional distress during the training process as they work on their cognitive challenges.
urochester Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Select...
I can take care of my daily needs without help.
urochester Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
MAAT-G Feasibility
Secondary outcome measures
Change in cognitive function
Qualitative assessment of feasibility
Usability
urochester Trial Design
1Treatment groups
Experimental Treatment
Group I: MAAT-G InterventionExperimental Treatment1 Intervention
MAAT-G Workshops & participant workbook use (8 workshops)
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,028 Total Patients Enrolled
Allison MagnusonLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had cancer, finished treatment aimed at curing it, and may be on maintenance therapy.I can understand and agree to the study's details on my own, or with a health care proxy if needed.I have mild cognitive impairment with a low score on the MOCA or MOCA-BLIND test.I am 65 years old or older.I can take care of my daily needs without help.
Research Study Groups:
This trial has the following groups:- Group 1: MAAT-G Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many subjects are contributing to this clinical research?
"Affirmative. According to clinicaltrials.gov, this research initiative is recruiting and was first advertised on December 10th 2021 before the latest update in February 17th 2022. A total of 35 individuals are needed for a single site trial."
Answered by AI
Could you tell me if this research project is recruiting participants?
"The details posted on clinicaltrials.gov suggest that this medical trial is recruiting patients. The experiment was initially announced on December 10th 2021 and underwent its most recent amendment February 17th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger